EMA – EMA and EORTC multi-stakeholder Follow-up workshop on soft tissue and bone sarcoma 24 May 2024: meeting report and event materials now available
The European Medicines Agency (EMA) and the European Organisation of Research and Treatment of Cancer (EORTC) organised a workshop on soft tissue and bone sarcoma on 12th January 2024 addressing the question on how we can develop new treatments in ultra-rare sarcomas, as a model for ultra-rare tumours.
This second workshop, held the 24 May 2024, was organised to discuss more in depth certain aspects as a follow-up discussion. Specifically, the workshop covered topics such as how to support an ecosystem for ultra-rare cancers and discuss lessons learned on specific examples.
Find the video recording, the presentation materials as well as the Report of the event on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (21 octobre 2024). EMA – EMA and EORTC multi-stakeholder Follow-up workshop on soft tissue and bone sarcoma 24 May 2024: meeting report and event materials now available. ELSIBI. Consulté le 18 février 2025 à l’adresse https://doi.org/10.58079/12jhe